Article Information
History
- December 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tomiko T Oskotsky1,
- Arohee Bhoja1,3,
- Daniel Bunis1,
- Brian L Le1,2,
- Idit Kosti1,2,
- Christine Li1,
- Sahar Houshdaran4,
- Sushmita Sen4,
- Júlia Vallvé-Juanico4,
- Wanxin Wang4,
- Erin Arthurs5,
- Lauren Mahoney5,
- Lindsey Lang5,
- Brice Gaudilliere6,
- David K Stevenson7,
- Juan C Irwin4,
- Linda C Giudice4,
- Stacy McAllister5 and
- Marina Sirota1,2,*
- 1Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA
- 2Department of Pediatrics, UCSF, San Francisco, CA
- 3Carnegie Mellon University, Pittsburgh, PA
- 4Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF, San Francisco, CA
- 5Gynecology and Obstetrics, Gynecology and Obstetrics, Emory University, Atlanta, GA
- 6Department of Anesthesiology, Pain and Perioperative Medicine, Stanford University, Stanford, CA
- 7Department of Pediatrics, Stanford University, Stanford, CA
- ↵* Corresponding author; email: marina.sirota{at}ucsf.edu
Posted December 21, 2022.
Applying a computational transcriptomics-based drug repositioning pipeline to identify therapeutic candidates for endometriosis
